Your browser doesn't support javascript.
loading
Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia A.
Sanabria, Martin; Álvarez Román, María Teresa; Castaman, Giancarlo; Janbain, Maissaa; Matsushita, Tadashi; Meijer, Karina; Oldenburg, Johannes; Friedl, Sabine; Reding, M T.
Afiliación
  • Sanabria M; Department of Hematology, Bayer AG, Basel, Switzerland.
  • Álvarez Román MT; Hematology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Castaman G; Center for Bleeding Disorders and Coagulation, Department of Oncology, University Hospital Careggi, Firenze, Italy.
  • Janbain M; Center for Bleeding and Clotting Disorders, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Matsushita T; Department of Blood Transfusion Service, Nagoya University Hospital, Nagoya, Japan.
  • Meijer K; Faculty of Medical Sciences, University Medical Centre Groningen, Groningen, Netherlands.
  • Oldenburg J; Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
  • Friedl S; Department of Oncology and Heamatology, Bayer AG, Berlin, Germany.
  • Reding MT; Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, Minnesota, USA redin002@umn.edu.
BMJ Open ; 11(9): e044997, 2021 09 02.
Article en En | MEDLINE | ID: mdl-34475142

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hemofilia A Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hemofilia A Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Suiza